Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis
Authors:
- 1 April 2022
- journal article
- research article
- Published by Elsevier in Cancer Genetics
- Vol. 262-263, 1-4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32-CA-09679)
This publication has 15 references indexed in Scilit:
- Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young AdultsJAMA Neurology, 2017
- A remarkably simple genome underlies highly malignant pediatric rhabdoid cancersJournal of Clinical Investigation, 2012
- SMARCB1 Deficiency in Tumors From the Peripheral Nervous SystemAmerican Journal of Surgical Pathology, 2012
- Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysisCancer, 2011
- Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomasJournal of Medical Genetics, 2010
- Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumorGenes, Chromosomes and Cancer, 2009
- Neurofibromatosis type 2The Lancet, 2009
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid TumorJournal of Clinical Oncology, 2009
- Evidence of a four-hit mechanism involvingSMARCB1andNF2in schwannomatosis-associated schwannomasHuman Mutation, 2007
- Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entityJournal of Neurosurgery, 1996